These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1127583)

  • 41. Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.
    Bernatchez SF; Tabatabay C; Gurny R
    Graefes Arch Clin Exp Ophthalmol; 1993 Mar; 231(3):157-61. PubMed ID: 8462888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.
    Miller SC; Himmelstein KJ; Patton TF
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):653-77. PubMed ID: 7341754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theoretical corneal permeation model for ionizable drugs.
    Friedrich SW; Cheng YL; Saville BA
    J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precorneal sampling techniques for ophthalmic gels.
    Ding S; Chen CC; Salome-Kesslak R; Tang-Liu DD; Himmelstein KJ
    J Ocul Pharmacol; 1992; 8(2):151-9. PubMed ID: 1506756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs.
    Douet JY; Michel J; Regnier A
    Am J Vet Res; 2013 Oct; 74(10):1321-6. PubMed ID: 24066916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels.
    Gilbard JP; Rossi SR; Heyda KG; Dartt DA
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1381-8. PubMed ID: 2365569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
    Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
    Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J; Wang L; Gao C; Zhang L; Xia H
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tear secretion and lacrimal gland function of rabbits treated with isotretinoin.
    Rismondo V; Ubels JL; Osgood TB
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 1):280-5. PubMed ID: 3170794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of ofloxacin in tear by HPLC-ESI-MS/MS method: comparison of ophthalmic drug release between a new mucoadhesive chitosan films and a conventional eye drop formulation in rabbit model.
    Byrro RM; de Oliveira Fulgêncio G; da Silva Cunha A; César IC; Chellini PR; Pianetti GA
    J Pharm Biomed Anal; 2012 Nov; 70():544-8. PubMed ID: 22673938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.
    Choi SM; Lee YG; Seo MJ; Kang KK; Ahn BO; Yoo M
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):209-14. PubMed ID: 19456255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.
    Samudre S; Lattanzio FA; Lossen V; Hosseini A; Sheppard JD; McKown RL; Laurie GW; Williams PB
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6265-70. PubMed ID: 21087963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
    Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
    Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of topical aqueous sirolimus on tear production in normal dogs and dogs with refractory dry eye.
    Spatola R; Nadelstein B; Berdoulay A; English RV
    Vet Ophthalmol; 2018 May; 21(3):255-263. PubMed ID: 28972684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bevacizumab eye drop treatment stimulates tear secretion in rats through changes in VEGF and NGF lacrimal gland levels.
    Rossi S; Mantelli F; Lambiase A; Aloe L
    Arch Ital Biol; 2012 Mar; 150(1):15-21. PubMed ID: 22786834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mathematical model for ocular tear and solute balance.
    Zhu H; Chauhan A
    Curr Eye Res; 2005 Oct; 30(10):841-54. PubMed ID: 16251121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.
    Wilson WS; Duncan AJ; Jay JL
    Br J Ophthalmol; 1975 Nov; 59(11):667-9. PubMed ID: 1203224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.